{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:10:57Z","timestamp":1776773457668,"version":"3.51.2"},"reference-count":17,"publisher":"BMJ","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thorax"],"published-print":{"date-parts":[[1986,10,1]]},"DOI":"10.1136\/thx.41.10.737","type":"journal-article","created":{"date-parts":[[2008,12,13]],"date-time":"2008-12-13T03:22:59Z","timestamp":1229138579000},"page":"737-739","source":"Crossref","is-referenced-by-count":67,"title":["Ocular toxicity from ethambutol."],"prefix":"10.1136","volume":"41","author":[{"given":"K M","family":"Citron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G O","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","article-title":"Annual Report and Accounts. No 92","author":"Society, I.Medical Protection","year":"1984","unstructured":"I Medical Protection Society. Annual Report and Accounts. No 92. London: Medical Protection Society, 1984:21."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0041-3879(65)80059-9","article-title":"Chemotherapy regimens used in re-treatment of pulmonary tuberculosis. Part II. Observations on the efficacy of continuation of ethambutol, capreomycin and combined drugs including 4-4 diisoamyloxythiosemicarbamanilide","volume":"46","author":"Kass, I.","year":"1965","unstructured":"Kass I. Chemotherapy regimens used in re-treatment of pulmonary tuberculosis. Part II. Observations on the efficacy of continuation of ethambutol, capreomycin and combined drugs including 4-4 diisoamyloxythiosemicarbamanilide. Tubercle 1965;46: 166.","journal-title":"Tubercle"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1749-6632.1966.tb45532.x","article-title":"The ocular toxicity of ethambutol and its relation to dose","volume":"135","author":"Leibold, J.E.","year":"1966","unstructured":"Leibold JE. The ocular toxicity of ethambutol and its relation to dose. Ann NY Acad Sci 1966;135:904.","journal-title":"Ann NY Acad Sci"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0041-3879(72)90012-8","article-title":"ethambutol and capreomycin in pulmonary tuberculosis previously treated with both first and second line drugs: the results of 2 years chemotherapy","volume":"53","author":"Aquinas, M.; Rifampicin, Citron K.M.","year":"1972","unstructured":"Aquinas M, Citron KM. Rifampicin, ethambutol and capreomycin in pulmonary tuberculosis previously treated with both first and second line drugs: the results of 2 years chemotherapy. Tubercle 1972;53: 153-65.","journal-title":"Tubercle"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0041-3879(73)90031-7","article-title":"Co-operative controlled trial of a standard regimen of streptomycin PAS and isoniazid, and three alternative regimens of chemotherapy in Britain","volume":"54","author":"Council, British Medical Research","year":"1973","unstructured":"British Medical Research Council. Co-operative controlled trial of a standard regimen of streptomycin PAS and isoniazid, and three alternative regimens of chemotherapy in Britain. Tubercle 1973;54:99-129.","journal-title":"Tubercle"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0002-9394(74)90684-9","article-title":"Ocular toxicity from ethambutol","volume":"77","author":"Barron, G.J.; Tepper, L.; Gino, I.","year":"1974","unstructured":"Barron GJ, Tepper L, Gino I. Ocular toxicity from ethambutol. Am J Ophthalmol 1974;77:256-60.","journal-title":"Am J Ophthalmol"},{"key":"ref_7","first-page":"1","article-title":"A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the re-treatment of patients with pulmonary tuberculosis in Hong Kong","volume":"55","author":"Services, Hong Kong Tuberculosis Treatment; Hospital, Brompton; Council, British Medical Research","year":"1974","unstructured":"Hong Kong Tuberculosis Treatment Services, Brompton Hospital, and British Medical Research Council. A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the re-treatment of patients with pulmonary tuberculosis in Hong Kong. Tubercle 1974;55:1-27.","journal-title":"Tubercle"},{"key":"ref_8","first-page":"921","article-title":"Controlled clinical trial comprising","volume":"129","author":"Group, Algerian Working; Council, British Medical Research","year":"1984","unstructured":"Algerian Working Group and British Medical Research Council. Controlled clinical trial comprising a 6 month and a 12 month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Am Rev Respir Dis 1984;129:921-8.","journal-title":"Am Rev Respir Dis; in the treatment of pulmonary tuberculosis in the Algerian Sahara"},{"key":"ref_9","first-page":"417","article-title":"British Medical Research Council. A service programme of anti-tuberculosis chemotherapy with five drugs for four months in the treatment of drug addicts and persons with pulmonary tuberculosis in Hong Kong","volume":"122","author":"and, Hong Kong","year":"1980","unstructured":"Hong Kong and British Medical Research Council. A service programme of anti-tuberculosis chemotherapy with five drugs for four months in the treatment of drug addicts and persons with pulmonary tuberculosis in Hong Kong. Am Rev Respir Dis 1980;122:417-24.","journal-title":"Am Rev Respir Dis"},{"key":"ref_10","first-page":"171","article-title":"Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis","volume":"i:","author":"Kong, Hong; Council, British Medical Research","year":"1981","unstructured":"Hong Kong and British Medical Research Council. Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Lancet 1981;i:171-4.","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0041-3879(83)90023-5","article-title":"Chest Service and British Medical Research Council. A service programme with a 6-month intensive chemotherapy regimen in the treatment of drug addicts and prisoners with pulmonary tuberculosis in Hong Kong","volume":"64","author":"Kong, Hong","year":"1983","unstructured":"Hong Kong Chest Service and British Medical Research Council. A service programme with a 6-month intensive chemotherapy regimen in the treatment of drug addicts and prisoners with pulmonary tuberculosis in Hong Kong. Tubercle 1983;64:265-74.","journal-title":"Tubercle"},{"key":"ref_12","first-page":"1182","article-title":"Short course chemotherapy in pulmonary tuberculosis. Third report","volume":"i:","author":"British Thoracic Association","year":"1980","unstructured":"British Thoracic Association. Short course chemotherapy in pulmonary tuberculosis. Third report. Lancet 1980;i: 1182.","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0007-0971(81)90046-2","article-title":"A controlled trial of six months chemotherapy in pulmonary tuberculosis. First report","volume":"75","author":"British Thoracic Association","year":"1981","unstructured":"British Thoracic Association. A controlled trial of six months chemotherapy in pulmonary tuberculosis. First report. Br J Dis Chest 1981;75:141.","journal-title":"Br J Dis Chest"},{"key":"ref_14","first-page":"460","article-title":"A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report","volume":"126","author":"British Thoracic Association","year":"1982","unstructured":"British Thoracic Association. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report. Am Rev Respir Dis 1982;126:460.","journal-title":"Am Rev Respir Dis"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0007-0971(86)90066-5","article-title":"Ocular toxicity following ethambutol in standard dosage","volume":"80","author":"Chatterjee, V.K.K.; Buchanan, D.R.; Al, Freidmann; Green, M.","year":"1986","unstructured":"Chatterjee VKK, Buchanan DR, Freidmann Al, Green M. Ocular toxicity following ethambutol in standard dosage. Br J Dis Chest 1986;80:288-91.","journal-title":"Br J Dis Chest"},{"key":"ref_16","first-page":"27","article-title":"Personal communication quoted in Tubercle","volume":"67","author":"Fox, W.","year":"1986","unstructured":"Fox W. Personal communication quoted in Tubercle. 1986;67:27."},{"issue":"50","key":"ref_17","first-page":"32","article-title":"A review with special reference to ocular toxicity","volume":"1969","author":"Ethambutol, Citron K.M.","unstructured":"Citron KM. Ethambutol. A review with special reference to ocular toxicity. Tubercle 1969;50(March suppl): 32-6.","journal-title":"Tubercle"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thx.41.10.737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T09:02:37Z","timestamp":1601110957000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thx.41.10.737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,10,1]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1986,10,1]]}},"URL":"https:\/\/doi.org\/10.1136\/thx.41.10.737","relation":{},"ISSN":["0040-6376"],"issn-type":[{"value":"0040-6376","type":"print"}],"subject":[],"published":{"date-parts":[[1986,10,1]]}}}